Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2003

  1. Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

    Annals of Oncology, Vol. 14, Núm. 8, pp. 1246-1252

  2. Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients

    Annals of Oncology, Vol. 14, Núm. 9, pp. 1383-1390